Sam Goldsmith

Sam Goldsmith, PhD, is an advanced therapy commercialization professional and published scientist with interests in research commercialization, venture capital, and novel medical technologies. From 2016 to 2020, Sam worked as a Business Manager at LifeArc, facilitating the commercialization of academic research. Following that, Sam was a University Liaison Manager at Cell and Gene Therapy Catapult, establishing collaborations in the advanced therapy space. Sam has also served as a Postdoctoral Research Scientist at The Francis Crick Institute and held various roles in technology transfer and intellectual property management, demonstrating a commitment to driving innovation in life sciences. Currently, Sam is a Board Observer at Plurify and a Non-Executive Director at Spliceor.